Replies to post #24541 on RespireRx Pharmaceuticals Inc (fka RSPI)

[atheroprevent]

Great data, Dew and Neuro.

I am surprised as many as 1 in five of the business transactions culminated in successful NDA. The 50% still in the works will probably have a greater rate of attrition, as they go back to the drawing board again and again to meet the FDA requests.